102849-49-0,
(2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid,
(S)-2-(2-oxopyrrolidin-1-yl)butanoic acid,
UNII-S19061909R,
2-(2-Oxopyrrolidin-1-yl)butanoic acid, (2S)-,
1-Pyrrolidineacetic acid, alpha-ethyl-2-oxo-, (alphaS)-,
(2S)-2-(2-Oxopyrrolidin-1-yl)butanoicacid,
(2s)-2- (2- oxopyrrolidin -1-yl) butanoic acid,
S19061909R,
(2S)-2-(2-oxo-1-pyrrolidinyl)butanoic acid,
Levetiracetam Carboxylic Acid,
J-501010,
(S)-Levetiracetam acid,
Levetiracetam acid, (-)-,
2-Pyrrolidinone-N-butyric acid,
UCB-L 057,
CHEMBL1287,
Levetiracetam impurity, levetiracetam acid- [USP],
SCHEMBL1877216,
Jsp000311,
CTK4A1548,
DTXSID00145541,
CHEBI:143418,
IODGAONBTQRGGG-LURJTMIESA-N,
ANW-45230,
CO-042,
FCH858918,
MFCD08272027,
ZINC13559003,
AKOS006285768,
AKOS015841982,
AB44229,
AC-1460,
LS30300,
RP23344,
RTC-020885,
(2S)-2-(2-Oxopyrrolizino)butyric acid,
AJ-64178,
AK-32691,
AN-14891,
AN-34152,
BC209263,
N757,
O366,
AX8005416,
DB-005503,
ST2414572,
TC-020885,
TL8000134,
TX-017670,
(s)-2-(2-oxopyrrolidin-1-yl) butyric acid,
FT-0600415,
FT-0674887,
(S)-alpha-ethyl-2-oxo pyrrolidine acetic acid,
(|AS)-|A-Ethyl-2-oxo-1-pyrrolidineacetic Acid,
(2S)-2- (2-oxopyrrolidin-1-yl) butanoic acid,
(s)-alpha-ethyl-2-oxo-1-pyrrolidineacetic acid,
1-Pyrrolidineaceticacid, a-ethyl-2-oxo-, (aS)-,
833O723,
849O490,
A800630,
C-34192,
(2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanoic acid,
(S)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRIC ACID,
UNII-T5GZ0UL12V component IODGAONBTQRGGG-LURJTMIESA-N,
Levetiracetam acid,
C8H13NO3,
RW1383,
CS-O-05917,
2-(2-oxopyrrolidin-1-yl)butanoic Acid,
CID11607993,
103833-72-3,
(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetic acid (R)-alpha-methylbenzenemethanamine salt,
102916-46-1,